Hanmi Science Competitors and Similar CompaniesClear all

Hanmi Science's competitors and similar companies include Grupo Menarini, AOP Orphan Pharmaceuticals, Zydus Lifesciences and Medochemie.

	Hanmi Science Hanmi is a company that manufactures and sells pharmaceutical products.	Grupo Menarini Grupo Menarini is a pharmaceutical company.	AOP Orphan Pharmaceuticals AOP Orphan is a company focused on clinical development, marketing and distribution of medicines for rare and complex diseases.	Zydus Lifesciences Zydus Lifesciences (formerly known as Cadila Healthcare) is a company that provides healthcare solutions.	Medochemie Medochemie is a pharmaceutical company.
Founding Date	Founding Date 1973	Founding Date 1961	Founding Date 1996	Founding Date 1952	Founding Date 1976
Type	Type Public	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations HQ	Locations Badalona, ES HQ	Locations Wien, AT HQ Sofia, BG Meudon, FR Ismaning, DE Athina, GR Budapest, HU see more	Locations Ahmedabad, IN HQ Rio De Janeiro, BR Nanterre, FR Ahmedabad, IN Ambernath, IN Ankleshwar, IN Bengaluru, IN see more	Locations Λεμεσός, CY HQ Ben Aknoun, DZ Amman, JO Rīga, LV Chișinău, MD Moscow, RU
Employees	Employees 428365% increase	Employees 5541% increase	Employees 5352% increase	Employees 27,9176% increase	Employees 825
Financial
Revenue (est.)	Revenue (est.) ₩1.4t (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹267.2b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹72.9b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit ₩1.4t (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit ₹203.7b (FY, 2026)	Gross profit N/A
Net income	Net income ₩117.7b (FY, 2025)	Net income N/A	Net income N/A	Net income ₹50.3b (FY, 2026)	Net income N/A